← Home

EDE

Tech / AI / DefenseDOWNTREND

$0.105

as of 2026-07-27

5d return

-8.7%

20d return

-27.6%

60d return

-44.7%

RSI 14

37.5

vs 52w high

-59.6%

vs 52w low

+377.3%

SMA 20

Below

SMA 50

Below

Price · Volume · Broker flow
Markers = announcements (red triangle = price-sensitive). Volume amber = ≥2× ADV spike. Flow bars stacked per broker group. Flow lags T+3.
Loading chart…
Closest correlates
Pearson r on log returns, window: 42d
  • AONr=0.45, window: 42d
  • LACr=0.45, window: 42d
  • AISr=0.44, window: 42d
  • AR1r=0.42, window: 42d
  • AYAr=0.41, window: 42d
Announcements — last 30 days
  • Eden is securing multi-state equipment rollout from major customer Amrize (NYSE: AMRZ, ~19,000 employees), indicating validated product traction and potential for recurring supply revenue. However, the US$32k initial order is modest in absolute terms relative to a $73m market cap, and the announcement lacks detail on equipment capex, installation timeline, or volume ramp potential.

  • EdenCrete has achieved positive trial results with the Indian government, indicating potential traction in a large emerging-market infrastructure sector. Without detail on scale, timeline to commercialisation, or revenue impact, the announcement appears exploratory rather than revenue-material at this stage.

  • 2026-07-06PSsubstantial_holderCeasing to be a substantial holder

    UBS has fully exited its substantial holding in Eden Innovations through a series of sells and a rehypothecated position return, suggesting opportunistic or portfolio-driven liquidation rather than operational concern. The exit follows a 19% share price decline over 20 days, positioning UBS's exit as a trailing move into weakness.